These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Pichichero ME, Casey JR. Diagn Microbiol Infect Dis; 2007 Oct; 59(2):127-30. PubMed ID: 17908614 [Abstract] [Full Text] [Related]
8. Frequency of symptomatic relapses of group A beta-hemolytic streptococcal tonsillopharyngitis in children from 4 pediatric practices following penicillin, amoxicillin, and cephalosporin antibiotic treatment. Casey JR, Kahn R, Gmoser D, Atlas E, Urbani K, Luber S, Pellman H, Pichichero ME. Clin Pediatr (Phila); 2008 Jul; 47(6):549-54. PubMed ID: 18490665 [Abstract] [Full Text] [Related]
16. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E. Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121 [Abstract] [Full Text] [Related]
17. Resistant pneumococci: protecting patients through judicious use of antibiotics. Dowell SF, Schwartz B. Am Fam Physician; 1997 Apr; 55(5):1647-54, 1657-8. PubMed ID: 9105195 [Abstract] [Full Text] [Related]
18. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections. Klein JO. Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220 [Abstract] [Full Text] [Related]